Michael Stowasser Selected Research

Renin

1/2022	Detecting primary aldosteronism in Australian primary care: a prospective study.
1/2022	Aldosterone-producing adenoma associated with non-suppressed renin: a case series.
1/2020	Effects of Ramipril on the Aldosterone/Renin Ratio and the Aldosterone/Angiotensin II Ratio in Patients With Primary Aldosteronism.
1/2020	Measurement of Equilibrium Angiotensin II in the Diagnosis of Primary Aldosteronism.
12/2017	Can Screening and Confirmatory Testing in the Management of Patients with Primary Aldosteronism be Improved?
1/2017	Effect of Moxonidine on the Aldosterone/Renin Ratio in Healthy Male Volunteers.
1/2017	Effect of Combined Hormonal Replacement Therapy on the Aldosterone/Renin Ratio in Postmenopausal Women.
1/2016	The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
9/2015	Should aldosterone suppression tests be conducted during a particular phase of the menstrual cycle, and, if so, which phase? Results of a preliminary study.
9/2015	The utility of renal venous renin studies in selection of patients with renal artery stenosis for angioplasty: a retrospective study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Stowasser Research Topics

Disease

59	Hyperaldosteronism (Conn Syndrome) 01/2022 - 02/2002
36	Hypertension (High Blood Pressure) 05/2022 - 11/2003
21	Adenoma (Adenomas) 01/2022 - 11/2003
10	Familial Hyperaldosteronism 01/2019 - 12/2004
9	Hyperplasia 12/2021 - 11/2003
6	Essential Hypertension 08/2015 - 07/2003
4	Hypokalemia 10/2016 - 09/2008
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 11/2012
2	Obesity 01/2021 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 10/2012
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2016 - 01/2015
2	Renal Artery Obstruction (Renal Artery Stenosis) 09/2015 - 01/2014
2	Chronic Renal Insufficiency 04/2014 - 10/2012
2	Proteinuria 04/2014 - 12/2013
2	Hypertrophy 09/2011 - 08/2004
2	Fibrosis (Cirrhosis) 09/2011 - 08/2004
2	Glucocorticoid-Remediable Aldosteronism 08/2008 - 11/2003
1	Neoplasms (Cancer) 01/2020
1	Hyperthyroidism 06/2017
1	Ageusia (Hypogeusia) 01/2016
1	Hemorrhage 01/2016
1	Pheochromocytoma 11/2015
1	Paraganglioma (Paragangliomas) 11/2015
1	Adrenocortical Adenoma (Disease, Conn's) 01/2015
1	Cushing Syndrome 01/2015
1	Inflammation (Inflammations) 04/2014
1	Renovascular Hypertension (Goldblatt Syndrome) 01/2014
1	Albuminuria 12/2013
1	Obstructive Sleep Apnea 04/2013
1	Gordon syndrome 06/2011
1	Dehydration (Water Stress) 05/2010
1	Retinoblastoma (Glioblastoma, Retinal) 12/2006
1	Alkalosis 09/2006

Drug/Important Bio-Agent (IBA)

56	AldosteroneIBA 01/2022 - 02/2002
26	ReninIBA 01/2022 - 02/2002
11	SaltsIBA 05/2022 - 06/2011
7	FludrocortisoneIBA 01/2020 - 11/2003
7	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2020 - 07/2003
7	GlucocorticoidsIBA 01/2015 - 12/2004
6	Dietary SodiumIBA 05/2022 - 12/2003
6	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 10/2009
6	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020 - 05/2010
5	SodiumIBA 01/2019 - 04/2013
4	Mineralocorticoid Receptor AntagonistsIBA 01/2016 - 09/2008
3	MineralocorticoidsIBA 10/2021 - 09/2006
3	Angiotensin IIIBA 01/2020 - 10/2016
3	Potassium Channels (Potassium Channel)IBA 04/2014 - 03/2012
3	Spironolactone (Aldactone)FDA LinkGeneric 09/2011 - 11/2003
3	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 08/2008 - 12/2004
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2021 - 11/2012
2	SteroidsIBA 01/2020 - 01/2018
2	AnionsIBA 01/2019 - 01/2018
2	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2019 - 05/2014
2	PotassiumIBA 01/2019 - 12/2003
2	moxonidine (Moxon)IBA 12/2017 - 01/2017
2	Member 3 Solute Carrier Family 12IBA 01/2017 - 05/2014
2	Adrenocorticotropic Hormone (ACTH)FDA Link 11/2016 - 01/2015
2	CreatinineIBA 04/2014 - 07/2009
2	Proteins (Proteins, Gene)FDA Link 04/2014 - 12/2006
2	Amiloride (Midamor)FDA LinkGeneric 09/2011 - 11/2003
1	Chloride-Bicarbonate AntiportersIBA 10/2021
1	LigandsIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Ramipril (Altace)FDA LinkGeneric 01/2020
1	Phosphotransferases (Kinase)IBA 01/2019
1	ChloridesIBA 01/2019
1	DiureticsIBA 01/2019
1	Chloride Channels (Chloride Channel)IBA 01/2018
1	Prazosin (Minipress)FDA LinkGeneric 12/2017
1	Verapamil (Calan)FDA LinkGeneric 12/2017
1	Hydralazine (Apresoline)FDA LinkGeneric 12/2017
1	CarbimazoleIBA 06/2017
1	thyrotropin-binding inhibitory immunoglobulinIBA 06/2017
1	Sodium Chloride SymportersIBA 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016
1	CatecholaminesIBA 11/2015
1	Clonidine (ST 155)FDA LinkGeneric 11/2015
1	Dichlorodiphenyldichloroethane (DDD)IBA 09/2015
1	Ion Channels (Ion Channel)IBA 01/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2015
1	SymportersIBA 05/2014
1	ThiazidesIBA 05/2014
1	AlbuminsIBA 04/2014
1	AdiponectinIBA 04/2014
1	pro-brain natriuretic peptide (1-76)IBA 04/2014
1	AdipokinesIBA 04/2014
1	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2014
1	DNA (Deoxyribonucleic Acid)IBA 04/2014
1	Pentetic Acid (DTPA)FDA LinkGeneric 01/2014
1	drospirenone FDA LinkGeneric 06/2011
1	Combined Oral ContraceptivesIBA 06/2011
1	Mixed Function Oxygenases (Monooxygenases)IBA 05/2010
1	Biomarkers (Surrogate Marker)IBA 05/2010
1	Interleukin-6 (Interleukin 6)IBA 04/2009

Therapy/Procedure

16	Adrenalectomy 12/2020 - 11/2003
5	Therapeutics 01/2022 - 10/2009
1	Blood Transfusion (Blood Transfusions) 01/2016
1	Nephrectomy 01/2014
1	Fluid Therapy (Oral Rehydration Therapy) 05/2010
1	Resistance Training 03/2009